Cargando…
Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c
BACKGROUND: Piezo1 has been revealed to play a regulatory role in vascular development and progression of variety tumors. However, whether and how the progression of hepatocellular carcinoma (HCC) regulated by Piezo1 remains elusive. This study aimed to elucidate the effect and mechanisms of Piezo1...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035260/ https://www.ncbi.nlm.nih.gov/pubmed/35461277 http://dx.doi.org/10.1186/s12935-022-02574-2 |
_version_ | 1784693257802874880 |
---|---|
author | Li, Yi-ming Xu, Cong Sun, Bo Zhong, Fang-jing Cao, Momo Yang, Lian-yue |
author_facet | Li, Yi-ming Xu, Cong Sun, Bo Zhong, Fang-jing Cao, Momo Yang, Lian-yue |
author_sort | Li, Yi-ming |
collection | PubMed |
description | BACKGROUND: Piezo1 has been revealed to play a regulatory role in vascular development and progression of variety tumors. However, whether and how the progression of hepatocellular carcinoma (HCC) regulated by Piezo1 remains elusive. This study aimed to elucidate the effect and mechanisms of Piezo1 in HCC. METHODS: The mRNA and protein expression level of Piezo1 in HCC samples and cell lines was determined by qRT-PCR, western blot and immunohistochemistry analyses. Two independent study cohorts containing 280 patients were analyzed to reveal the association between Piezo1 expression and clinicopathological characteristics. Series of in vitro and in vivo experiments were used to validate the function of Piezo1 in HCC. Gene set enrichment analysis (GSEA) was performed to explore the signaling pathway of Piezo1. Immunoprecipitation, immunofluorescence and in vitro and in vivo experiments were used to explore the molecular mechanism of Piezo1 in HCC progression. RESULTS: Our results demonstrated the Piezo1 expression was significantly upregulated in HCC tissues and cell lines, and upregulation of Piezo1 closely correlated with aggressive clinicopathological features and poor prognosis. Knockdown of Piezo1 in HCCLM3 and Hep3B cells significantly restrained proliferation, migration, invasion and epithelial–mesenchymal transition (EMT) of HCC cells in vitro, and tumor growth, metastasis, EMT in vivo. TGF-β signaling pathway was most significant enriched pathway in GSEA. Finally, tumor promotion effect of Piezo1 was found to exerted through recruiting and combining Rab5c to activating TGF-β signaling pathway. CONCLUSIONS: Piezo1 significantly related to poor prognosis and promotes progression of hepatocellular carcinoma via activating TGF-β signaling, which suggesting that Piezo1 may serve as a novel prognostic predictor and the potential therapeutic target for HCC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-022-02574-2. |
format | Online Article Text |
id | pubmed-9035260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90352602022-04-25 Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c Li, Yi-ming Xu, Cong Sun, Bo Zhong, Fang-jing Cao, Momo Yang, Lian-yue Cancer Cell Int Primary Research BACKGROUND: Piezo1 has been revealed to play a regulatory role in vascular development and progression of variety tumors. However, whether and how the progression of hepatocellular carcinoma (HCC) regulated by Piezo1 remains elusive. This study aimed to elucidate the effect and mechanisms of Piezo1 in HCC. METHODS: The mRNA and protein expression level of Piezo1 in HCC samples and cell lines was determined by qRT-PCR, western blot and immunohistochemistry analyses. Two independent study cohorts containing 280 patients were analyzed to reveal the association between Piezo1 expression and clinicopathological characteristics. Series of in vitro and in vivo experiments were used to validate the function of Piezo1 in HCC. Gene set enrichment analysis (GSEA) was performed to explore the signaling pathway of Piezo1. Immunoprecipitation, immunofluorescence and in vitro and in vivo experiments were used to explore the molecular mechanism of Piezo1 in HCC progression. RESULTS: Our results demonstrated the Piezo1 expression was significantly upregulated in HCC tissues and cell lines, and upregulation of Piezo1 closely correlated with aggressive clinicopathological features and poor prognosis. Knockdown of Piezo1 in HCCLM3 and Hep3B cells significantly restrained proliferation, migration, invasion and epithelial–mesenchymal transition (EMT) of HCC cells in vitro, and tumor growth, metastasis, EMT in vivo. TGF-β signaling pathway was most significant enriched pathway in GSEA. Finally, tumor promotion effect of Piezo1 was found to exerted through recruiting and combining Rab5c to activating TGF-β signaling pathway. CONCLUSIONS: Piezo1 significantly related to poor prognosis and promotes progression of hepatocellular carcinoma via activating TGF-β signaling, which suggesting that Piezo1 may serve as a novel prognostic predictor and the potential therapeutic target for HCC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-022-02574-2. BioMed Central 2022-04-23 /pmc/articles/PMC9035260/ /pubmed/35461277 http://dx.doi.org/10.1186/s12935-022-02574-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Primary Research Li, Yi-ming Xu, Cong Sun, Bo Zhong, Fang-jing Cao, Momo Yang, Lian-yue Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c |
title | Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c |
title_full | Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c |
title_fullStr | Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c |
title_full_unstemmed | Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c |
title_short | Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c |
title_sort | piezo1 promoted hepatocellular carcinoma progression and emt through activating tgf-β signaling by recruiting rab5c |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035260/ https://www.ncbi.nlm.nih.gov/pubmed/35461277 http://dx.doi.org/10.1186/s12935-022-02574-2 |
work_keys_str_mv | AT liyiming piezo1promotedhepatocellularcarcinomaprogressionandemtthroughactivatingtgfbsignalingbyrecruitingrab5c AT xucong piezo1promotedhepatocellularcarcinomaprogressionandemtthroughactivatingtgfbsignalingbyrecruitingrab5c AT sunbo piezo1promotedhepatocellularcarcinomaprogressionandemtthroughactivatingtgfbsignalingbyrecruitingrab5c AT zhongfangjing piezo1promotedhepatocellularcarcinomaprogressionandemtthroughactivatingtgfbsignalingbyrecruitingrab5c AT caomomo piezo1promotedhepatocellularcarcinomaprogressionandemtthroughactivatingtgfbsignalingbyrecruitingrab5c AT yanglianyue piezo1promotedhepatocellularcarcinomaprogressionandemtthroughactivatingtgfbsignalingbyrecruitingrab5c |